INTRODUCTION
India’s nutraceutical market is growing at an exponential pace, offering significant potential for global manufacturers aiming to expand in Asia. However, navigating the Food Safety and Standards Authority of India (FSSAI) regulations can be challenging without a structured roadmap. This comprehensive guide walks you through the step-by-step process of registering Over-the-Counter (OTC) nutraceuticals and Foods for Special Medical Purposes (FSMPs) in India, based on the latest regulatory framework outlined in FSSAI’s 2022 regulations.
UNDERSTANDING INDIA’S NUTRACEUTICAL REGULATORY EVOLUTION
India’s regulatory approach to nutraceuticals is relatively new compared to the well-established compliance paths for pharmaceuticals and cosmetics. The foundation was laid in 2006 with the enactment of the Food Safety and Standards Act, which enabled the free import of nutraceuticals. In 2008, FSSAI was established as an autonomous regulatory body to oversee the food safety landscape. A pivotal shift came in 2016, when comprehensive regulations were introduced for health supplements, nutraceuticals, foods for dietary use, FSMPs, and pre/probiotics. By 2022, these were further refined with updated product categories, safety guidelines, and clarity on ingredient standards consolidate India’s commitment to safe and regulated health food products
DECODING PRODUCT CATEGORIES UNDER FSSAI
Before initiating the registration process, it’s essential to identify the correct classification for your product. FSSAI has categorized nutraceutical products under various headings, each with unique regulatory implications. For instance, Nutraceuticals are intended to provide physiological benefits such as anti-inflammatory or heart-health support and include ingredients like curcumin or omega-3. Health Supplements, such as multivitamins or protein powders, are designed to complement the normal diet. Meanwhile, FSMPs are specially formulated for patients with medical conditions and are typically consumed under medical supervision for example, ICU feeding formulas. Other important categories include Foods for Special Dietary Use (FSDU), Plant/Botanical-Based Foods, and Prebiotics/Probiotics. Each of these categories is governed by different labelling rules, ingredient approvals, and Recommended Dietary Allowance (RDA) considerations, making it vital to determine your classification early.
THE ROLE OF INGREDIENT SCHEDULES AND RDA LIMITS
FSSAI follows a schedule-based approval system. Ingredients are grouped into nine schedules, covering everything from essential nutrients (vitamins, minerals, amino acids) and plant/botanical ingredients to food additives, probiotics, and prebiotic compounds.
If your product contains substances listed within these schedules, it has a smoother path to approval. However, if an ingredient is absent or presented in a novel form (like nano-formulations or fermented extracts), it may fall under the Non-Specified Food (NSF) category, requiring a separate application and more rigorous review. Just as important are RDA limits, which must be tailored to Indian reference standards.
The RDA is based on typical body weights for Indian adults (60 kg for men and 55 kg for women) and considers various activity levels and age groups. Products exceeding RDA thresholds or intended for non-standard populations (e.g., lactating mothers or children) may be flagged for further scrutiny, without matching the ingredient values to Indian RDA guidelines, your application risks rejection — this step is mandatory under FSSAI regulation.
LABELLING, CLAIMS, AND COMPLIANCES UNDER INDIAN LAW
Labelling is one of the most critical aspects of regulatory compliance under FSSAI. According to the Food Safety and Standards (Labelling and Display) Regulations, 2020, product labels must clearly communicate the product’s nutritional value, ingredients, manufacturer/importer details, and FSSAI license number. Specific warnings are also required — for instance, caffeine-containing products must state: “Not recommended for children, pregnant or lactating women.”
Additionally, claims must adhere to the FSSAI Advertising and Claims Regulations, 2018. These are divided into five schedules:
- Schedule I deals with nutrient content claims (e.g., “low fat”, “high fiber”),
- Schedule II mandates warnings for certain substances,
- Schedule III allows for permitted disease risk reduction claims (e.g., “oats may reduce cholesterol”),
- Schedule IV focuses on fortified foods,
- Schedule V defines how terms like “natural” or “pure” can be used legally.
Misleading or unsubstantiated claims can lead to regulatory rejection or post-market penalties, so it’s imperative to review all packaging materials before submission.
Check out our latest blog to learn more for Fssai Labelling Regulations
WHEN DOES YOUR PRODUCT BECOME A NON-SPECIFIED FOOD (NSF)?
If your product contains ingredients not approved in the listed schedules, or if it is manufactured using new technologies or processes unfamiliar in the Indian context (such as nano-processing or microbial fermentation), it qualifies as a Non-Specified Food (NSF). NSF applications are reviewed with heightened caution and require extensive documentation.
To succeed with an NSF application, you must provide:
- Detailed product composition and functional use,
- Ingredient source data and consumption history,
- Toxicology, allergenicity, and efficacy studies,
- NABL/ILAC-accredited lab test reports,
- Regulatory approval status in other countries.
Processing time for NSF approvals typically ranges from 4 to 6 months, and FSSAI may request additional evidence if concerns are raised. Without compelling documentation, your application may be delayed indefinitely.
Check out our latest blog to learn more for Non-Specified Food (NSF) Registration Process
FILING FORM B: STANDARD REGISTRATION PATHWAY
For products falling under approved categories, the Form B application is the standard route. It is submitted via the FoSCoS portal, and the following documents are essential:
- Manufacturer authorization or No Objection Certificate (NOC),
- Full ingredient breakdown compliant with Indian regulations,
- GMP or ISO certification
- Certificate of Analysis (CoA),
- Label copy aligned with Indian labelling norms,
- Test reports supporting product claims.
The process takes 2–3 months, with registration valid for 1 to 5 years. The current fee is approximately INR 7,500 (GBP 75). It’s advisable to prepare all documents upfront to avoid delays due to regulatory queries.
Check out our latest blog to learn more for Form B For Nutraceutical Products
IMPORT PROCESS AND ROLE OF THE AUTHORIZED INDIAN AGENT
Once the product is approved, the next step is customs clearance, which involves submission of the shipping documentation, physical inspection, and lab testing by port officers. Any misalignment in labeling or formulation may lead to rejections or penalties at this stage. Importers must ensure all packaging reflects the updated Indian-compliant label and importer details — this may be done through over-stickering, but only under pre-approved guidelines.
A crucial partner in this journey is your Independent Authorized Indian Agent (IAA). Indian regulations require foreign manufacturers to appoint an IAA to act as a liaison with FSSAI and handle everything from application filing to post-market surveillance. This is not just a legal requirement — it’s a strategic partnership. Choosing a capable, experienced agent can significantly streamline your approval and import process, while a poor choice can create long-term regulatory and business obstruction.
PREPARING FOR THE FUTURE: FSSAI VS. CDSCO JURISDICTION
While FSSAI currently governs nutraceuticals, India’s Central Drugs Standard Control Organisation (CDSCO) is beginning to review products that blur the lines between food and drugs. A panel was set up in 2024 to assess whether some high-dose or therapeutic nutraceuticals should fall under CDSCO instead. If your product makes strong medical claims, delivers pharmacologically active dosages, or is used in clinical settings, you should monitor this transition closely.
Registering such products under CDSCO is more time-consuming (6–9 months minimum), involves higher costs, and stricter documentation similar to drug registrations. Therefore, brands operating in this regulatory “grey zone” must stay agile and plan for dual compliance scenarios when entering India.
HOW MORULAA HEALTHTECH CAN HELP
At Morulaa HealthTech, we understand that compliance is not just about ticking boxes, it’s about enabling your product to succeed in a highly regulated and competitive market. With more than a decade of experience, a portfolio of over 5,000+ SKUs, and clients in over 30 countries, our regulatory team comprising PhDs and MPharm experts offers deep knowledge of FSSAI, CDSCO, IVD, and cosmetics compliance.
We go beyond paperwork. Our support spans:
- Registration and NSF approvals,
- Appointing and managing IAAs,
- Label and claim alignment,
- Distributor coordination,
- Ensuring uninterrupted import flow and market access.
With our on-ground expertise and integrated regulatory-marketing approach, we help you reduce the cost and complexity of entering the Indian market while ensuring your product reaches its full commercial potential.